The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Automatic Insulin Delivery Systems Market Research Report 2025
Synopsis
The Automatic Insulin Delivery Systems, also known as artificial pancreas or hybrid closed loop automatically manages or withholds insulin in response to blood glucose measurements (via using continuous glucose monitors (CGMs) and smart algorithms).
The global Automatic Insulin Delivery Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Asia-Pacific region is the largest and fastest-growing market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Automatic Insulin Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automatic Insulin Delivery Systems.
Report Scope
The Automatic Insulin Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automatic Insulin Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automatic Insulin Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lily
Tandem
Insulet
Big Foot Biomedical
Segment by Type
Type I Diabetes
Type II Diabetes
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Automatic Insulin Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Automatic Insulin Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Automatic Insulin Delivery Systems, also known as artificial pancreas or hybrid closed loop automatically manages or withholds insulin in response to blood glucose measurements (via using continuous glucose monitors (CGMs) and smart algorithms).
The global Automatic Insulin Delivery Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Asia-Pacific region is the largest and fastest-growing market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Automatic Insulin Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automatic Insulin Delivery Systems.
Report Scope
The Automatic Insulin Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automatic Insulin Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automatic Insulin Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lily
Tandem
Insulet
Big Foot Biomedical
Segment by Type
Type I Diabetes
Type II Diabetes
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Automatic Insulin Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Automatic Insulin Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Automatic Insulin Delivery Systems Market Overview
1.1 Product Overview and Scope of Automatic Insulin Delivery Systems
1.2 Automatic Insulin Delivery Systems Segment by Type
1.2.1 Global Automatic Insulin Delivery Systems Market Value Comparison by Type (2024-2030)
1.2.2 Type I Diabetes
1.2.3 Type II Diabetes
1.3 Automatic Insulin Delivery Systems Segment by Application
1.3.1 Global Automatic Insulin Delivery Systems Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Diabetes Clinics
1.4 Global Automatic Insulin Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Automatic Insulin Delivery Systems Revenue 2019-2030
1.4.2 Global Automatic Insulin Delivery Systems Sales 2019-2030
1.4.3 Global Automatic Insulin Delivery Systems Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Automatic Insulin Delivery Systems Market Competition by Manufacturers
2.1 Global Automatic Insulin Delivery Systems Sales Market Share by Manufacturers (2019-2024)
2.2 Global Automatic Insulin Delivery Systems Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Automatic Insulin Delivery Systems Average Price by Manufacturers (2019-2024)
2.4 Global Automatic Insulin Delivery Systems Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Automatic Insulin Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Automatic Insulin Delivery Systems, Product Type & Application
2.7 Automatic Insulin Delivery Systems Market Competitive Situation and Trends
2.7.1 Automatic Insulin Delivery Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Automatic Insulin Delivery Systems Players Market Share by Revenue
2.7.3 Global Automatic Insulin Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Automatic Insulin Delivery Systems Retrospective Market Scenario by Region
3.1 Global Automatic Insulin Delivery Systems Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Automatic Insulin Delivery Systems Global Automatic Insulin Delivery Systems Sales by Region: 2019-2030
3.2.1 Global Automatic Insulin Delivery Systems Sales by Region: 2019-2024
3.2.2 Global Automatic Insulin Delivery Systems Sales by Region: 2025-2030
3.3 Global Automatic Insulin Delivery Systems Global Automatic Insulin Delivery Systems Revenue by Region: 2019-2030
3.3.1 Global Automatic Insulin Delivery Systems Revenue by Region: 2019-2024
3.3.2 Global Automatic Insulin Delivery Systems Revenue by Region: 2025-2030
3.4 North America Automatic Insulin Delivery Systems Market Facts & Figures by Country
3.4.1 North America Automatic Insulin Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Automatic Insulin Delivery Systems Sales by Country (2019-2030)
3.4.3 North America Automatic Insulin Delivery Systems Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Automatic Insulin Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Automatic Insulin Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Automatic Insulin Delivery Systems Sales by Country (2019-2030)
3.5.3 Europe Automatic Insulin Delivery Systems Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Automatic Insulin Delivery Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Automatic Insulin Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Automatic Insulin Delivery Systems Sales by Country (2019-2030)
3.6.3 Asia Pacific Automatic Insulin Delivery Systems Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Automatic Insulin Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Automatic Insulin Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Automatic Insulin Delivery Systems Sales by Country (2019-2030)
3.7.3 Latin America Automatic Insulin Delivery Systems Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Automatic Insulin Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Automatic Insulin Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Automatic Insulin Delivery Systems Sales by Country (2019-2030)
3.8.3 Middle East and Africa Automatic Insulin Delivery Systems Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Automatic Insulin Delivery Systems Sales by Type (2019-2030)
4.1.1 Global Automatic Insulin Delivery Systems Sales by Type (2019-2024)
4.1.2 Global Automatic Insulin Delivery Systems Sales by Type (2025-2030)
4.1.3 Global Automatic Insulin Delivery Systems Sales Market Share by Type (2019-2030)
4.2 Global Automatic Insulin Delivery Systems Revenue by Type (2019-2030)
4.2.1 Global Automatic Insulin Delivery Systems Revenue by Type (2019-2024)
4.2.2 Global Automatic Insulin Delivery Systems Revenue by Type (2025-2030)
4.2.3 Global Automatic Insulin Delivery Systems Revenue Market Share by Type (2019-2030)
4.3 Global Automatic Insulin Delivery Systems Price by Type (2019-2030)
5 Segment by Application
5.1 Global Automatic Insulin Delivery Systems Sales by Application (2019-2030)
5.1.1 Global Automatic Insulin Delivery Systems Sales by Application (2019-2024)
5.1.2 Global Automatic Insulin Delivery Systems Sales by Application (2025-2030)
5.1.3 Global Automatic Insulin Delivery Systems Sales Market Share by Application (2019-2030)
5.2 Global Automatic Insulin Delivery Systems Revenue by Application (2019-2030)
5.2.1 Global Automatic Insulin Delivery Systems Revenue by Application (2019-2024)
5.2.2 Global Automatic Insulin Delivery Systems Revenue by Application (2025-2030)
5.2.3 Global Automatic Insulin Delivery Systems Revenue Market Share by Application (2019-2030)
5.3 Global Automatic Insulin Delivery Systems Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lily
6.1.1 Eli Lily Corporation Information
6.1.2 Eli Lily Description and Business Overview
6.1.3 Eli Lily Automatic Insulin Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lily Automatic Insulin Delivery Systems Product Portfolio
6.1.5 Eli Lily Recent Developments/Updates
6.2 Tandem
6.2.1 Tandem Corporation Information
6.2.2 Tandem Description and Business Overview
6.2.3 Tandem Automatic Insulin Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Tandem Automatic Insulin Delivery Systems Product Portfolio
6.2.5 Tandem Recent Developments/Updates
6.3 Insulet
6.3.1 Insulet Corporation Information
6.3.2 Insulet Description and Business Overview
6.3.3 Insulet Automatic Insulin Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Insulet Automatic Insulin Delivery Systems Product Portfolio
6.3.5 Insulet Recent Developments/Updates
6.4 Big Foot Biomedical
6.4.1 Big Foot Biomedical Corporation Information
6.4.2 Big Foot Biomedical Description and Business Overview
6.4.3 Big Foot Biomedical Automatic Insulin Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Big Foot Biomedical Automatic Insulin Delivery Systems Product Portfolio
6.4.5 Big Foot Biomedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Automatic Insulin Delivery Systems Industry Chain Analysis
7.2 Automatic Insulin Delivery Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Automatic Insulin Delivery Systems Production Mode & Process
7.4 Automatic Insulin Delivery Systems Sales and Marketing
7.4.1 Automatic Insulin Delivery Systems Sales Channels
7.4.2 Automatic Insulin Delivery Systems Distributors
7.5 Automatic Insulin Delivery Systems Customers
8 Automatic Insulin Delivery Systems Market Dynamics
8.1 Automatic Insulin Delivery Systems Industry Trends
8.2 Automatic Insulin Delivery Systems Market Drivers
8.3 Automatic Insulin Delivery Systems Market Challenges
8.4 Automatic Insulin Delivery Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
